Main Article Content

Abstract

Citrullus Lanatus is a medicinal plant with therapeutic potential, belongs to the family Cucurbitaceous, also known as, watermelon and is known for its anti-bacterial activity [1]. Recently, many biological activities of Citrullus Lanatus L. seeds have been reported, including traditionally, said to be medicinal because it can relieve inflammation irritation causes increased passing of urine and gives tonic effects and also cucurbit pepo (pumpkin), Citrullus Colocynths (bitter cucumber), among from that I have been taken Citrullus Lanatus seed (watermelon) is one of most effective and potential anti-bacterial activity, particularly in its seed [2]. The result of antibacterial activity indicate that effects of Citrullus Lanatas seed extract were tested on phytochemical, results showed the presence of alkaloids, flavonoids, corticoids, saponins and tannins in the extracts of Citrullus Lanatas. Among that results shows alkaloids and flavonoids were most effective compounds for the antibacterial activity in higher plants. Apart from that saponins show the most responsible and effectively compound for antibacterial activity of Citrullus Lanatas. In this study, two solvents were taken chloroform seed extracts and acetone seed extract from Citrullus Lanatus L. have been tested for Anti-bacterial activity [3]. The antibacterial activity of the extract was examined against Gram-Positive and Gram-Negative bacteria by measuring the zone of inhibition. Results showed acetone extract was increased linearly increasing different concentration of extracts (25 mg/ml, 50 mg/ml, 75 mg/ml, 100 mg/ml) against two pathogenic strains (Escherichia coli, Staphylococcus aureus), by disc diffusion method, as compared with standard drug such as ciprofloxacin and control as acetone, the antibacterial activity of acetone was good. All the two organisms used for screening have the similar sensitivity.


 

Keywords

Anti-antibacterial activity Citrullus Lanatus L. seed Ciprofloxacin Escherichia coli Bacillus Subtilis

Article Details

How to Cite
K. Naga Kumari, Md.Mansoor, CH.Ramya, & Shakeela. (2023). Evaluation Of Phytochemical And Anti-Bacterial Activity Of Citrillus Lanatus. International Journal of Research in Pharmacology & Pharmacotherapeutics, 12(2), 133-138. https://doi.org/10.61096/ijrpp.v12.iss2.2023.133-138

References

  1. 1. Mayers DL, Lerner SA, Ouellette M. Antimicrobial drug resistance C, clinical and epidemiological aspects, springer Dordrecht Heidelberg, London vol. 2009;2:681-1347.
  2. 2. Guschin A, Ryzhikh P, Rumyantseva T. treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin. BMC Infect Dis. 2015;15:1-7.
  3. 3. Martin I, Sawatzky P, Liu G, et al. Antimicrobial resistance to Neisseria gonorrheal in Canada. Can Commun Dis Rep. 2015;41, 2009–2013:40-1.
  4. 4. J. Berdy. Bioactive microbial metabolites J, Antibiot, this article is free to access. 2005;58:1-26.
  5. 5. Runyoro DK, Matee MI, Ngassapa OD, Joseph CC, Mbwambo ZH. Screening of Tanzanian medicinal plants for anti-Candida activity. BMC Complement Altern Med. 2006;6:11. doi: 10.1186/1472-6882-6-11, PMID 16571139.
  6. 6. Mabona U, A, Viljoen E, Shikanga. Antimicrobial activity of southern African medicinal plants with dermatological relevance: from an ethno pharmacological screening approach, to combination studies and the isolation of a bioactive compoundJ, Ethnopharmacol. 2013;148:45-55.
  7. 7. Nazzaro F, Fratianni F, De Martino L, Coppola R, De Feo V. Effect of essential oils on pathogenic bacteria. Pharmaceuticals (Basel). 2013;6(12):1451-74. doi: 10.3390/ph6121451, PMID 24287491.
  8. 8. Heatley NG. A method for the assay of penicillin. Biochem J. 1944;38(1):61-5. doi: 10.1042/bj0380061, PMID 16747749.
  9. 9. CLSI, performance standards for antimicrobial disk susceptibility tests, approved standard. 7th ed [CLSI document]. Vol. 19087. USA; 2012. p. M02-A11.
  10. 10. CLSI, method for antifungal disk diffusion susceptibility testing of yeasts, approved guideline. CLSI document M44-A. CLSI. Vol. M44-A. USA; 2004. p. 19087-1898.
  11. 11. 11.I, Martin P, Sawatzky GL, et al. Antimicrobial resistance to Neisseria gonorrheal in Canada. Can Commun Dis Rep. 2015;41, 2009–2013:40-1.
  12. 12. J. Berdy. Bioactive microbial metabolites J, Antibiot, this article is free to access. 2005;58:1-26.
  13. 13. Runyoro DK, Matee MI, Ngassapa OD, Joseph CC, Mbwambo ZH. Screening of Tanzanian medicinal plants for anti-Candida activity. BMC Complement Altern Med. 2006;6:11. doi: 10.1186/1472-6882-6-11, PMID 16571139.
  14. 14. Mabona U, A, Viljoen E, Shikanga. Antimicrobial activity of southern African medicinal plants with dermatological relevance: from an ethno pharmacological screening approach, to combination studies and the isolation of a bioactive compoundJ, Ethnopharmacol. 2013;148:45-55.
  15. 15. Nazzaro F, Fratianni F, De Martino L, Coppola R, De Feo V. Effect of essential oils on pathogenic bacteria. Pharmaceuticals (Basel). 2013;6(12):1451-74. doi: 10.3390/ph6121451, PMID 24287491.
  16. 16. Heatley NG. A method for the assay of penicillin. Biochem J. 1944;38(1):61-5. doi: 10.1042/bj0380061, PMID 16747749.
  17. 17. CLSI, performance standards for antimicrobial disk susceptibility tests, approved standard. 7th ed [CLSI document]. Vol. 19087. USA; 2012. p. M02-A11.
  18. 18. CLSI, method for antifungal disk diffusion susceptibility testing of yeasts, approved guideline. CLSI document M44-A. CLSI. Vol. M44-A. USA; 2004. p. 19087-1898.